Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Lorrain Daniel S.
Over the trailing 90 days, Lorrain Daniel S. (Other Officer at Contineum Therapeutics, Inc.) traded $700K of stock (net selling $632K) in CTNM, per 14 SEC Form 4 transactions.
- Role
- Other Officer
- Companies
- CTNM
- Window
- Trailing 90 days · 14 transactions · CIK 1861550
- Net activity
- −$632K ($34K bought · $666K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 14 | $34K | $666K | −$632K |
Transactions (14)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-09 | CTNM | Sell | 25 | $0 | Exercise or conversion of derivative security |
| 2026-07-09 | CTNM | Buy | 25 | $25 | Exercise or conversion of derivative security |
| 2026-07-09 | CTNM | Sell | 25 | $400 | Open market or private sale |
| 2026-07-08 | CTNM | Sell | 1.0K | $0 | Exercise or conversion of derivative security |
| 2026-07-08 | CTNM | Sell | 1.0K | $16K | Open market or private sale |
| 2026-07-08 | CTNM | Buy | 1.0K | $1K | Exercise or conversion of derivative security |
| 2026-07-01 | CTNM | Sell | 4.2K | $0 | Exercise or conversion of derivative security |
| 2026-07-01 | CTNM | Buy | 4.2K | $4K | Exercise or conversion of derivative security |
| 2026-07-01 | CTNM | Sell | 2.5K | $41K | Open market or private sale |
| 2026-07-01 | CTNM | Sell | 5.9K | $92K | Open market or private sale |
| 2026-06-30 | CTNM | Buy | 28.8K | $29K | Exercise or conversion of derivative security |
| 2026-06-30 | CTNM | Sell | 28.8K | $462K | Open market or private sale |
| 2026-06-30 | CTNM | Sell | 28.8K | $0 | Exercise or conversion of derivative security |
| 2026-06-01 | CTNM | Sell | 4.2K | $55K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Lorrain's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.